Noridian retires draft DCIS biomarker LCD and cancels October 13 meeting
Oct 11, 2026 edition · GC-2026-0282 · Published 2026-10-11 · Version 3 · Withdrawn
Noridian retired proposed DCIS biomarker LCD DL40144 and canceled its October 13 advisory meeting. This is withdrawal of a draft, rather than a new final coverage rule. The notice cites comments about current and impending clinical evidence and directs readers to monitor further updates.
What happened
Noridian retired the proposed MolDX Biomarker Testing for Risk Stratification in DCIS local coverage determination, DL40144, effective October 8, 2026. Its notice identifies the affected JE Part B contracts covering Northern and Southern California, Nevada, Hawaii and listed Pacific territories. It also cancels the Contractor Advisory Committee meeting scheduled for October 13. The date describes retirement of the proposal, not implementation of a new final coverage requirement.
The stated reason is the volume of comments concerning current and impending clinical evidence that the contractor needs to consider. Noridian says further updates will appear on its website and directs readers seeking the retired proposal to the Medicare Coverage Database archive. Providers should distinguish a withdrawn draft from rules actually in force. The notice does not itself establish a new covered indication, universal noncoverage or a replacement proposal’s timing.
Scope and timing
- Authority status
- Withdrawn
- Applicability
- Directly applicable
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Affected functions
- Coding, Clinical Operations, Revenue Cycle
- Responsible owner
- Coding
Why it matters
The retirement responds to comments about current and emerging evidence. Retiring a proposed LCD does not establish that an existing covered benefit was withdrawn.
Recommended action
Remove the canceled meeting from monitoring plans and continue using actual operative coverage rules while watching any replacement proposal. Playbook dates are recommended internal targets, except any explicitly identified agency date.
Sources
- Noridian DCIS proposed LCD retirementOfficial · Noridian JE Part B · 2026-10-08 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →